Metabolomic and transcriptomic profiling of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas

Carcinogenesis

Volumn 34, Issue 6, 2013, Pages 1251-1259

  Yabushita, Setsuko ^a   Fukamachi, Katsumi ^b   Tanaka, Hajime ^b   Fukuda, Takako ^a   Sumida, Kayo ^a   Deguchi, Yoshihito ^a   Mikata, Kazuki ^a   Nishioka, Kazuhiko ^a   Kawamura, Satoshi ^a   Uwagawa, Satoshi ^a   Suzui, Masumi ^b   Alexander, David B ^b,c   Tsuda, Hiroyuki ^c  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE LYASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; FATTY ACID SYNTHASE; NUCLEOTIDE; PALMITOLEIC ACID;

ANAEROBIC GLYCOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; FATTY ACID BLOOD LEVEL; FATTY ACID SYNTHESIS; GENE EXPRESSION; HISTOPATHOLOGY; MALE; MASS FRAGMENTOGRAPHY; METABOLIC PARAMETERS; METABOLOMICS; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PANCREAS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; TRANSCRIPTOMICS; TRICHLOROACETIC ACID CYCLE;

5-LIPOXYGENASE-ACTIVATING PROTEINS; ADENOCARCINOMA; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS, MONOUNSATURATED; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, RAS; GLYCOLYSIS; HUMANS; METABOLOMICS; NUCLEOTIDES; PANCREATIC NEOPLASMS; RATS; RATS, TRANSGENIC; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878980627     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt053     Document Type: Article

References (20)

1. Jemal,A. et al. (2003) Cancer statistics, 2003. CA Cancer J. Clin., 53, 5-26.
2. Akdogan,M. et al. (2001) Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature. Tumori, 87, 337-339.
3. Ni,X.G. et al. (2005) The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur. J. Surg. Oncol., 31, 164-169.
4. Duffy,M.J. (1998) CA 19-9 as a marker for gastrointestinal cancers: a review. Ann. Clin. Biochem., 35 (Pt 3), 364-370.
5. Ueda,S. et al. (2006) Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. Carcinogenesis, 27, 2497-2510.
6. Fiehn,O. (2002) Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol., 48, 155-171.
7. Nicholson,J.K. et al. (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29, 1181-1189.
8. Beckonert,O. et al. (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc., 2, 2692-2703.
9. Dettmer,K. et al. (2007) Mass spectrometry-based metabolomics. Mass Spectrom. Rev., 26, 51-78.
10. Weckwerth,W. et al. (2005) Metabolomics: from pattern recognition to biological interpretation. Drug Discov. Today, 10, 1551-1558.
11. Sreekumar,A. et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 457, 910-914.
12. Tanaka,H. et al. (2010) Mature acinar cells are refractory to carcinoma development by targeted activation of Ras oncogene in adult rats. Cancer Sci., 101, 341-346.
13. Fukamachi,K. et al. (2009) An animal model of preclinical diagnosis of pancreatic ductal adenocarcinomas. Biochem. Biophys. Res. Commun., 390, 636-641.
14. Garber,K. (2004) Energy boost: the Warburg effect returns in a new theory of cancer. J. Natl Cancer Inst., 96, 1805-1806.
15. Warburg,O. (1956) On the origin of cancer cells. Science, 123, 309-314.
16. Menendez,J.A. et al. (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer, 7, 763-777.
17. Tiziani,S. et al. (2009) Early stage diagnosis of oral cancer using 1H NMRbased metabolomics. Neoplasia, 11, 269-276, 4p following 269.
18. Hirayama,A. et al. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-offlight mass spectrometry. Cancer Res., 69, 4918-4925.
19. Nishiumi,S. et al. (2010) Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics, 6, 518-528.
20. Urayama,S. et al. (2010) Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun. Mass Spectrom., 24, 613-620.